The pharmaceutical and biotechnology company Moderna, Inc. (MRNA) has submitted an application to Swissmedic for the authorized use of its COVID-19 vaccine in …
The pharmaceutical and biotechnology company Moderna, Inc. (MRNA) has collaborated with Tabuk Pharmaceuticals to market its COVID-19 Vaccine and future, variant-specific booster candidates, …
Pharmaceutical and biotechnology company Moderna (MRNA) has filed an application with the U.S.
The shares of the pharmaceutical and biotechnology company, Moderna Inc. (MRNA), rose 6.
Biotechnology company Moderna Inc. (MRNA) has inked an additional drug substance manufacturing agreement with Lonza.
Shares of Moderna Inc. (MRNA) jumped 3.
Moderna, Inc. (MRNA) is expanding its partnership with Aldevron, LLC to support the biotech company’s COVID-19 vaccine and other programs in its development …
Shares of Moderna Inc. (MRNA) declined 2.
Moderna, Inc. (MRNA) has won a new order for the supply of 25 million doses of its COVID-19 vaccine to Australia.
Moderna (MRNA) reported better-than-expected 1Q earnings and the first profitable quarter in its history. Meanwhile, revenues for the quarter missed analysts’ expectations.
